A carregar...

Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem

Vaborbactam is a novel beta-lactamase inhibitor with activity against important beta-lactamases, in particular, serine carbapenemases, and is currently approved in combination with meropenem as Vabomere for the treatment of complicated urinary tract infections, including pyelonephritis. This combina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Griffith, David C., Sabet, Mojgan, Tarazi, Ziad, Lomovskaya, Olga, Dudley, Michael N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325214/
https://ncbi.nlm.nih.gov/pubmed/30397063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01659-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!